Literature DB >> 33418734

Gradient-on-a-Chip with Reactive Oxygen Species Reveals Thresholds in the Nucleus Response of Cancer Cells Depending on the Matrix Environment.

Shirisha Chittiboyina1, Rahim Rahimi2,3, Farzaneh Atrian1, Manuel Ochoa2,3, Babak Ziaie2,3,4, Sophie A Lelièvre1,3,4.   

Abstract

Oxidative stress-mediated cancer progression depends on exposure to reactive oxygen species (ROS) in the extracellular matrix (ECM). To study the impact of ROS levels on preinvasive breast cancer cells as a function of ECM characteristics, we created a gradient-on-a-chip in which H2O2 progressively mixes with the cell culture medium within connected microchannels and diffuses upward into the ECM of the open cell culture window. The device utilizes a paper-based microfluidic bifurcating mixer insert to prevent leakage and favor an even fluid distribution. The gradient was confirmed by measuring H2O2 catalyzed into oxygen, and increasing oxidative DNA damage and protective (AOP2) response were recorded in 2D and ECM-based 3D cell cultures. Interestingly, the impact of ROS on nuclear shape and size (annunciating phenotypical changes) was governed by the stiffness of the collagen I matrix, suggesting the existence of thresholds for the phenotypic response to microenvironmental chemical exposure depending on ECM conditions.

Entities:  

Keywords:  3D cell culture; DNA damage; cancer progression; cell nucleus; nuclear morphology; oxidative stress

Year:  2017        PMID: 33418734     DOI: 10.1021/acsbiomaterials.7b00087

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  2 in total

1.  Editorial: Special Issue on Tissue Engineering and Biomaterials Approaches to Tumor Modeling.

Authors:  Claudia Fischbach; Michaela Reagan
Journal:  ACS Biomater Sci Eng       Date:  2018-02-12

2.  3D Cell Culture for the Study of Microenvironment-Mediated Mechanostimuli to the Cell Nucleus: An Important Step for Cancer Research.

Authors:  Apekshya Chhetri; Joseph V Rispoli; Sophie A Lelièvre
Journal:  Front Mol Biosci       Date:  2021-02-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.